Practical consensus recommendations for polytherapy involving stiripentol in Dravet syndrome: A nominal group approach

Documenti analoghi

• Practical considerations for the use of fenfluramine to manage patients with Dravet syndrome or Lennox–Gastaut syndrome in clinical practice
  di: Elaine C. Wirrell, et al.
  Pubblicazione: (2024)
• Consensus panel recommendations for the optimization of EPIDIOLEX® treatment for seizures associated with Lennox–Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex
  di: Robert T. Wechsler, et al.
  Pubblicazione: (2024)
• Stiripentol use in Dravet syndrome patients in the USA : Results of a real‐world study
  di: Elaine Wirrell, et al.
  Pubblicazione: (2025)
• Comparative efficacy and safety of stiripentol, cannabidiol and fenfluramine as first‐line add‐on therapies for seizures in Dravet syndrome: A network meta‐analysis
  di: Renzo Guerrini, et al.
  Pubblicazione: (2024)
• Communicating a diagnosis of Dravet syndrome to parents/caregivers: An international Delphi consensus
  di: Andreas Brunklaus, et al.
  Pubblicazione: (2025)